Results 71 to 80 of about 365,564 (297)

Isolated undersized mitral annuloplasty for functional mitral regurgitation in non-ischemic dilated cardiomyopathy: reconsideration of the relationship between preoperative coaptation depth and persistent mitral regurgitation. [PDF]

, 2008
A preoperative coaptation depth (CD) >or=11 mm is apparently a predictive factor for persistent mitral regurgitation (MR) after undersized mitral annuloplasty for functional MR.
Eishi, Kiyoyuki, Tada, Seiichi, Yamane, Kentaro, Nakaji, Shun, Yamachika, Shiro, Tanigawa, Kazuyoshi, Miura, Takashi, Hashizume, Koji   +7 more
core  

Double Transeptal Puncture for SAPIEN M3 Transcatheter Mitral Valve Replacement: Initial Experience, Indications, and Technique

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The SAPIEN M3 system has been recently approved for transcatheter mitral valve replacement (TMVR). The transeptal guide sheath is used to deploy the dock, which is completely released before inserting and deploying the M3 valve using the same femoral access, transeptal puncture (TSP) and guide sheath.
Clara Fernandez‐Cordon, David Hoare, Aayush Singal, Sanjeev Bhattacharyya, Suneil K. Aggarwal, Michael J. Mullen   +5 more
wiley   +1 more source

Advances in transcatheter mitral and tricuspid therapies

BMC Cardiovascular Disorders, 2020
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk, Nicolo Piazza, Juan Granada, Osama Soliman, Bernard Prendergast, Thomas Modine   +5 more
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Evaluation of Echocardiography Results after Severe Mitral Valve Regurgitation Repair Surgery

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2018
BACKGROUND AND OBJECTIVE: Severe mitral valve regurgitation, which occurs primarily or secondary to various cardiovascular diseases, has undergone surgery and valve replacement and artificial valve insertion from several years ago.
MT Salehi Omran, HR Vafaei, H Salehi Omran   +2 more
doaj  

Percutaneous Repair for Secondary Mitral Regurgitation

, 2019
To the Editor: Obadia et al. (Dec. 13 issue)(1) describe the results of the MITRA-FR trial (Percutaneous Repair with the MitraClip Device for Severe Functional/Secondary Mitral Regurgitation), a randomized, controlled trial of this device for ...
Munafò, Andrea, Godino, Cosmo, Margonato, Alberto   +2 more
core   +1 more source

Early- and Long-Term Outcomes of Mitral Valve Repair in a Low-Volume Centre in the Caribbean

Brazilian Journal of Cardiovascular Surgery, 2021
Introduction: This study examines early- and long-term outcomes of mitral valve repairs in a low-volume cardiac surgery centre in the Caribbean. Methods: Ninety-six consecutive patients underwent mitral valve repair from April 2009 to December 2018 ...
Richard A. E. Ramsingh, Gianni D. Angelini, Risshi D. Rampersad, Natasha C. Rahaman, Giovanni Teodori   +4 more
doaj   +1 more source

Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years

European Journal of Heart Failure, 2019
The MITRA‐FR trial showed that among symptomatic patients with severe secondary mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for heart failure at 12 months compared with guideline‐directed medical ...
B. Iung, X. Armoiry, A. Vahanian, Florent Boutitie, N. Mewton, J. Trochu, T. Lefèvre, D. Messika-Zeitoun, P. Guérin, B. Cormier, E. Brochet, H. Thibault, D. Himbert, S. Thivolet, G. Leurent, Guillaume Bonnet, E. Donal, N. Piriou, C. Piot, Gilbert Habib, F. Rouleau, Didier Carrié, M. Nejjari, P. Ohlmann, Christophe Saint Etienne, Lionel Leroux, M. Gilard, Géraldine Samson, G. Rioufol, Delphine Maucort-Boulch, J. Obadia   +30 more
semanticscholar   +1 more source

Potential Prognostic Relevance of Left-Ventricular Global Longitudinal Strain and of the Summation of the Mitral and Tricuspid Regurgitation Volume in Patients with Non-Ischemic Dilated Cardiomyopathy

Journal of Cardiovascular Development and Disease, 2023
Background: The aim of this pilot study was to determine the potential prognostic relevance of novel multidirectional myocardial and volumetric echocardiographic parameters in patients with non-ischemic dilated cardiomyopathy (NIDCM).
Karolina Mėlinytė-Ankudavičė, Eglė Ereminienė, Vaida Mizarienė, Gintarė Šakalytė, Jurgita Plisienė, Renaldas Jurkevičius   +5 more
doaj   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source